Carl Zeiss Meditec has reported revenue of €2,066.1 million for its 2023/24 fiscal year, down by 1.1 percent in reported terms versus 2022/23. In constant currencies and adjusted from the effects of the acquisition of DORC, a company specializing in retinal surgery, total sales declined by 4.8 percent.
Buying a membership today will give you:
To continue reading this article register now.